Genscript Biotech Corporation Stock price

Equities

1548

KYG3825B1059

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. 04:08:03 2024-03-28 am EDT 5-day change 1st Jan Change
14.5 HKD +2.11% Intraday chart for Genscript Biotech Corporation -6.57% -26.99%
Sales 2023 840M 6.57B Sales 2024 * 1.27B 9.97B Capitalization 3.85B 30.16B
Net income 2023 -95M -743M Net income 2024 * -111M -868M EV / Sales 2023 6.43 x
Net cash position 2023 * 671M 5.25B Net cash position 2024 * 606M 4.74B EV / Sales 2024 * 2.55 x
P/E ratio 2023
-56.1 x
P/E ratio 2024 *
-38 x
Employees 6,937
Yield 2023 *
-
Yield 2024 *
-
Free-Float 54.04%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Genscript Biotech Corporation

1 day+2.11%
1 week-6.57%
Current month-8.34%
1 month-9.15%
3 months-26.69%
6 months-30.62%
Current year-26.99%
More quotes
1 week
14.02
Extreme 14.02
15.52
1 month
13.80
Extreme 13.8
18.00
Current year
12.56
Extreme 12.56
19.84
1 year
12.56
Extreme 12.56
24.95
3 years
12.56
Extreme 12.56
43.40
5 years
9.66
Extreme 9.66
43.40
10 years
1.07
Extreme 1.07
43.40
More quotes
Managers TitleAgeSince
Chief Executive Officer - 22-12-31
Founder 55 01-12-31
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member 61 15-08-23
Director/Board Member 74 09-12-31
Director/Board Member 65 15-08-23
More insiders
Date Price Change Volume
24-03-28 14.5 +2.11% 9 619 438
24-03-27 14.2 -1.93% 5,410,342
24-03-26 14.48 -2.82% 8,087,622
24-03-25 14.9 +1.78% 6,067,731
24-03-22 14.64 -5.67% 17,262,010

Delayed Quote Hong Kong S.E., March 28, 2024 at 04:08 am EDT

More quotes
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
1.815 USD
Average target price
3.688 USD
Spread / Average Target
+103.18%
Consensus
  1. Stock
  2. Equities
  3. Stock Genscript Biotech Corporation - Hong Kong S.E.